| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
Journal of the American Society of Nephrology, Vol 5, 1581-1584, Copyright © 1995 by American Society of Nephrology
REGULAR ARTICLES |
AB Haaber, I Eidemak, T Jensen, B Feldt-Rasmussen and S Strandgaard
Department of Nephrology, Herlev County Hospital, Denmark.
Cardiovascular risk factors and markers of endothelial cell function were studied in nondiabetic patients with mild to moderate chronic renal failure. The transcapillary escape rate of albumin and the plasma concentrations of von Willebrand factor, fibrinogen, and plasma lipids were measured in 29 nondiabetic patients (GFR of 25 (11-44) mL/min x 1.73 m2 (median and range)) and 14 normal subjects. The proportion of smokers was similar between the groups. In the patients, the plasma concentration of von Willebrand factor was elevated by 61% (1.27 +/- 0.44 versus 0.79 +/- 0.28 U/mL; P < 0.01) (mean +/- SD) and that of fibrinogen was elevated by 72% (10.18 +/- 4.14 versus 5.92 +/- 2.01 mumol/L; P < 0.01). The plasma concentrations of lipoproteins showed an atherogenic pattern in the patients with increased levels of very low- density lipoprotein cholesterol (0.57 +/- 0.31 versus 0.33 +/- 0.13 mmol/L; P < 0.01) and triglycerides (1.26 +/- 0.25 versus 0.71 +/- 0.28 mmol/L; P < 0.01), but a decreased level of high-density lipoprotein cholesterol (1.23 +/- 0.33 versus 1.46 +/- 0.35 mmol/L; P < 0.05). Total cholesterol and low-density lipoprotein cholesterol were similar in the groups. The observed differences were further aggravated among smoking patients, particularly with respect to von Willebrand factor and triglycerides. The transcapillary escape rate of albumin was similar in the patients and the controls and was not correlated to the level of albuminuria.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
R. Vanholder, U. Baurmeister, P. Brunet, G. Cohen, G. Glorieux, J. Jankowski, and for the European Uremic Toxin Work Group A Bench to Bedside View of Uremic Toxins J. Am. Soc. Nephrol., May 1, 2008; 19(5): 863 - 870. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Kushiya, H. Wada, M. Sakakura, Y. Mori, E. C. Gabazza, M. Nishikawa, T. Nobori, M. Noguchi, K. Izumi, T. Nakasaki, et al. Effects of Lipid Abnormalities on Arteriosclerosis and Hemostatic Markers in Patients under Hemodialysis Clinical and Applied Thrombosis/Hemostasis, July 1, 2003; 9(3): 203 - 210. [Abstract] [PDF] |
||||
![]() |
G. M. London, S. J. Marchais, A. P. Guerin, F. Metivier, and H. Adda Arterial structure and function in end-stage renal disease Nephrol. Dial. Transplant., October 1, 2002; 17(10): 1713 - 1724. [Full Text] [PDF] |
||||
![]() |
R. Pedrinelli, G. Dell'Omo, G. Penno, and M. Mariani Non-diabetic microalbuminuria, endothelial dysfunction and cardiovascular disease Vascular Medicine, November 1, 2001; 6(4): 257 - 264. [Abstract] [PDF] |
||||
![]() |
A. SEGARRA, P. CHACÓN, C. MARTINEZ-EYARRE, X. ARGELAGUER, J. VILA, P. RUIZ, J. FORT, J. BARTOLOMÉ, J. CAMPS, E. MOLINER, et al. Circulating Levels of Plasminogen Activator Inhibitor Type-1, Tissue Plasminogen Activator, and Thrombomodulin in Hemodialysis Patients: Biochemical Correlations and Role as Independent Predictors of Coronary Artery Stenosis J. Am. Soc. Nephrol., June 1, 2001; 12(6): 1255 - 1263. [Abstract] [Full Text] |
||||
![]() |
J Thambyrajah, M J Landray, F J McGlynn, H J Jones, D C Wheeler, and J N Townend Abnormalities of endothelial function in patients with predialysis renal failure Heart, February 1, 2000; 83(2): 205 - 209. [Abstract] [Full Text] |
||||
![]() |
G. Cianciolo, S. Stefoni, F. Zanchelli, S. Iannelli, L. Coli, L. C. Borgnino, L. B. De Sanctis, V. Stefoni, A. De Pascalis, E. Isola, et al. PDGF-AB release during and after haemodialysis procedure Nephrol. Dial. Transplant., October 1, 1999; 14(10): 2413 - 2419. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kunz, P. Petitjean, M. Lisri, F. Chantrel, C. Koehl, M.-L. Wiesel, J.-P. Cazenave, B. Moulin, and T. P. Hannedouche Cardiovascular morbidity and endothelial dysfunction in chronic haemodialysis patients: is homocyst(e)ine the missing link? Nephrol. Dial. Transplant., August 1, 1999; 14(8): 1934 - 1942. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kennon, A. Suliman, P. K. MacCallum, K. Ranjadayalan, P. Wilkinson, and A. D. Timmis Clinical characteristics determining the mode of presentation in patients with acute coronary syndromes J. Am. Coll. Cardiol., December 1, 1998; 32(7): 2018 - 2022. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673